Recombinant Xenopus laevis Transmembrane protein 53-A (tmem53-a)

What is TMEM53-A and what is its significance in Xenopus laevis research?

TMEM53-A is a transmembrane protein localized to the outer nuclear membrane (ONM) in Xenopus laevis. Based on comparative data, TMEM53 is highly conserved among species, with approximately 86.3% sequence identity between human and mouse homologs . In vertebrate models, TMEM53 functions as a regulatory protein involved in BMP-SMAD signaling pathways by preventing excessive nuclear accumulation of phosphorylated SMAD1/5/9 transcription factors .

Given that Xenopus laevis is a model of choice for evolutionary, comparative, and developmental studies, the recombinant TMEM53-A protein provides researchers with a valuable tool to investigate the conservation and divergence of nuclear envelope protein functions across species . The high degree of similarity between Xenopus and mammalian systems makes this protein particularly valuable for translational research approaches.

How does the amino acid sequence of Xenopus laevis TMEM53-A compare with mammalian orthologs?

While the search results don't provide the specific sequence for Xenopus laevis TMEM53-A, we can infer its likely conservation based on comparative data between other species. TMEM53 exhibits high conservation across vertebrates, with human and mouse TMEM53 showing 86.3% amino acid identity .

This conservation suggests that Xenopus laevis TMEM53-A likely shares significant sequence similarity with its mammalian counterparts, particularly in functional domains such as the transmembrane region. As a reference point, another Xenopus laevis transmembrane protein (TMEM163) consists of 281 amino acids with a specific sequence pattern that includes a transmembrane domain critical for its localization and function .

What expression systems are recommended for producing recombinant Xenopus laevis TMEM53-A?

Based on established protocols for similar Xenopus laevis transmembrane proteins, E. coli expression systems have proven effective for recombinant protein production . When expressing Xenopus laevis TMEM53-A, researchers should consider the following methodological approaches:

• Vector selection: Plasmids containing N-terminal or C-terminal His-tags facilitate purification while minimizing interference with protein function

• Expression conditions: Induction at lower temperatures (16-18°C) may improve proper folding of transmembrane proteins

• Solubilization strategies: Detergent selection is critical; mild non-ionic detergents often preserve transmembrane protein structure

• Purification approach: Immobilized metal affinity chromatography (IMAC) followed by size exclusion chromatography

For functional studies where proper folding and post-translational modifications are essential, researchers might consider eukaryotic expression systems such as insect cells (Sf9/Sf21) or mammalian cell lines as alternatives to E. coli.

What methodologies are recommended for studying TMEM53-A localization in Xenopus cells?

To investigate the subcellular localization of TMEM53-A in Xenopus cells, researchers should employ a multi-faceted approach:

• Immunocytochemistry (ICC): Using antibodies against TMEM53-A or epitope tags, researchers can visualize protein localization through confocal microscopy. Co-staining with nuclear envelope markers (e.g., lamin B1, SUN proteins) can confirm outer nuclear membrane localization .

• Subcellular fractionation: Separate nuclear envelope, nuclear, and cytoplasmic fractions through differential centrifugation, followed by Western blot analysis to detect TMEM53-A in specific cellular compartments.

• Proximity labeling approaches: BioID or APEX2 fusion proteins can identify proteins in close proximity to TMEM53-A, providing insights into its functional localization.

• Live-cell imaging: Express fluorescently-tagged TMEM53-A in Xenopus cells to monitor its dynamic localization during development or in response to stimuli.

These methods should be complemented with appropriate controls to validate specificity, including knockdown/knockout approaches to confirm antibody specificity .

How can researchers investigate the role of TMEM53-A in BMP signaling pathways in Xenopus laevis?

Based on mammalian studies, TMEM53 regulates BMP signaling by controlling the nuclear localization of phosphorylated SMAD1/5/9 . To investigate this function in Xenopus laevis, researchers should consider these methodological approaches:

• Nucleocytoplasmic distribution analysis:

  • Perform immunocytochemistry for phosphorylated SMAD1/5/9 in control versus TMEM53-A-depleted cells

  • Quantify the nuclear-to-cytoplasmic ratio of phosphorylated SMAD1/5/9 following BMP stimulation

  • Compare Western blot results of nuclear and cytoplasmic fractions

• Transcriptional activity assays:

  • Employ BMP-responsive luciferase reporter constructs to measure pathway activity

  • Analyze expression of known BMP target genes by qRT-PCR

  • Perform RNA-seq to identify global transcriptional changes

• Protein-protein interaction studies:

  • Co-immunoprecipitation to detect physical interactions between TMEM53-A and components of the BMP pathway

  • Proximity ligation assays to visualize interactions in situ

• Developmental phenotype analysis:

  • Morpholino-mediated knockdown of TMEM53-A during early development

  • CRISPR/Cas9-mediated mutation of TMEM53-A

  • Rescue experiments with wild-type versus mutant TMEM53-A

What phenotypes would be expected from TMEM53-A knockdown or knockout in Xenopus laevis?

Based on studies of TMEM53 deficiency in humans and mice, researchers might expect the following phenotypes when TMEM53-A function is disrupted in Xenopus laevis:

• Developmental abnormalities:

  • Normal development until later stages (equivalent to the late-onset phenotypes observed in mouse models)

  • Craniofacial abnormalities including altered head shape and potential hypertelorism

  • Shortened body length in tadpoles or metamorphosed frogs

• Skeletal alterations:

  • Thickening of cartilaginous structures (analogous to calvaria thickening in mice)

  • Altered vertebral development, potentially including flattened vertebral bodies

  • Changes in limb development during and after metamorphosis

• Cellular and molecular changes:

  • Enhanced osteoblast differentiation in relevant tissues

  • Increased nuclear localization of phosphorylated SMAD1/5/9

  • Upregulation of BMP target genes in affected tissues

• Functional consequences:

  • Potential impact on swimming behavior due to skeletal abnormalities

  • Possible sensory deficits analogous to vision impairment observed in human patients

Documentation of these phenotypes should include careful staging, morphometric analysis, histological examination, and molecular profiling.

How can TMEM53-A function in Xenopus laevis be compared with its function in mammalian systems?

For comparative functional analysis between Xenopus TMEM53-A and mammalian TMEM53, researchers should implement these methodological approaches:

• Rescue experiments:

  • Test if human or mouse TMEM53 can rescue phenotypes resulting from Xenopus TMEM53-A knockdown/knockout

  • Test if Xenopus TMEM53-A can restore normal function in TMEM53-deficient mammalian cells

  • Generate chimeric proteins to identify functionally conserved domains

• Comparative protein interaction studies:

  • Perform parallel co-immunoprecipitation studies in Xenopus and mammalian cells

  • Use BioID or APEX2 proximity labeling to identify interactors across species

  • Compare the ability of Xenopus TMEM53-A and mammalian TMEM53 to interact with components of the nuclear pore complex

• Evolutionary functional assessment:

  • Generate a TMEM53 phylogenetic tree across vertebrates to identify conserved functional domains

  • Perform domain-swapping experiments between species

  • Analyze sites under purifying versus positive selection

• Comparative developmental phenotyping:

  • Document developmental timing differences in phenotype manifestation between species

  • Analyze tissue-specific expression patterns across species using RNA-seq data

  • Compare transcriptional responses to TMEM53 modulation across species

What structural features of recombinant TMEM53-A are critical for its function at the nuclear envelope?

Understanding the structural determinants of TMEM53-A function requires detailed analysis of its domains and their relationships to cellular localization and signaling regulation:

• Transmembrane domain analysis:

  • The transmembrane domain is essential for proper localization to the nuclear envelope

  • Truncated versions of TMEM53 lacking the transmembrane domain fail to rescue signaling defects in knockout cells

  • Site-directed mutagenesis of conserved residues within this domain can identify critical anchoring motifs

• Functional domain mapping:

  • Generate truncation mutants to identify regions required for SMAD1/5/9 regulation

  • Create point mutations in conserved residues to identify those critical for function

  • Perform structure-function analyses using chimeric constructs with other nuclear envelope proteins

• Post-translational modification analysis:

  • Identify phosphorylation, ubiquitination, or other modifications that might regulate TMEM53-A function

  • Perform site-directed mutagenesis of potential modification sites

  • Test if modifications change in response to BMP pathway activation

• Structural analysis techniques:

  • Circular dichroism to assess secondary structure composition

  • Limited proteolysis to identify stable domains

  • If possible, X-ray crystallography or cryo-EM of purified protein or relevant domains

How can researchers differentiate between direct and indirect effects of TMEM53-A on BMP signaling?

Distinguishing direct from indirect effects of TMEM53-A on BMP signaling requires careful experimental design:

• Temporal resolution studies:

  • Perform time-course analyses after acute depletion of TMEM53-A (e.g., using auxin-inducible degron systems)

  • Compare immediate versus delayed transcriptional responses using RNA-seq

  • Track phosphorylated SMAD1/5/9 localization dynamics at short time intervals after TMEM53-A depletion

• Direct interaction assessment:

  • Test for physical interactions between TMEM53-A and SMAD proteins or nuclear pore complex components

  • Perform in vitro binding assays using purified components

  • Use FRET or BRET approaches to detect interactions in living cells

• Reconstitution experiments:

  • Develop in vitro nuclear transport assays using isolated nuclei

  • Test if addition of purified TMEM53-A alters nuclear transport of phosphorylated SMAD1/5/9

  • Reconstruct minimal systems using defined components

• Alternative pathway analysis:

  • Examine effects on other signaling pathways (e.g., TGF-β, Wnt, Hedgehog)

  • Test if TMEM53-A effects depend on intact BMP receptor signaling

  • Perform epistasis experiments by modulating upstream or downstream pathway components

What are the optimal storage and handling conditions for recombinant Xenopus laevis TMEM53-A protein?

Based on established protocols for similar transmembrane proteins from Xenopus laevis, researchers should follow these guidelines:

• Storage recommendations:

  • Store lyophilized protein at -20°C to -80°C for long-term stability

  • For working aliquots, store at 4°C for up to one week

  • Avoid repeated freeze-thaw cycles that can denature the protein

• Reconstitution protocol:

  • Briefly centrifuge vials before opening to bring contents to the bottom

  • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Add glycerol to a final concentration of 5-50% for improved stability

  • Prepare small single-use aliquots for long-term storage

• Buffer considerations:

  • Optimal buffer systems include Tris/PBS-based buffers at pH 8.0

  • Consider adding stabilizing agents such as 6% Trehalose

  • For functional studies, ensure buffer composition maintains native protein conformation

• Quality control measures:

  • Verify protein purity using SDS-PAGE (target >90% purity)

  • Confirm identity via Western blot analysis

  • Test functional activity using established assays

What approaches can be used to overcome challenges in expressing full-length TMEM53-A with proper folding?

Transmembrane proteins present unique challenges for recombinant expression. Researchers working with TMEM53-A should consider:

• Expression system optimization:

  • Compare prokaryotic (E. coli) versus eukaryotic (insect or mammalian) expression systems

  • Test different E. coli strains designed for membrane protein expression (e.g., C41(DE3), C43(DE3))

  • Optimize induction conditions (temperature, inducer concentration, duration)

• Solubilization strategies:

  • Screen detergent panels to identify optimal solubilization conditions

  • Consider nanodiscs or amphipols for maintaining native conformation

  • Test different lysis methods to improve extraction efficiency

• Fusion tags and constructs:

  • Compare N-terminal versus C-terminal His-tags

  • Test additional solubility-enhancing tags (MBP, SUMO, Trx)

  • Consider expressing functional domains separately if full-length expression is problematic

• Protein quality assessment:

  • Evaluate proper folding using circular dichroism or limited proteolysis

  • Perform functional assays to verify activity

  • Assess aggregation state using size exclusion chromatography or dynamic light scattering

How can researchers validate the specificity of antibodies for detecting Xenopus laevis TMEM53-A?

Ensuring antibody specificity is critical for accurate interpretation of TMEM53-A studies. Researchers should implement these validation strategies:

• Genetic validation approaches:

  • Test antibody reactivity in TMEM53-A knockout or knockdown samples

  • Overexpress tagged TMEM53-A and confirm co-localization with antibody signal

  • Compare staining patterns across tissues with known expression patterns from RNA-seq data

• Biochemical validation:

  • Perform Western blots to confirm single bands of appropriate molecular weight

  • Conduct peptide competition assays to demonstrate specific binding

  • Pre-absorb antibodies with recombinant protein to eliminate specific signal

• Cross-reactivity assessment:

  • Test antibodies against related proteins (e.g., other TMEM family members)

  • Compare multiple antibodies targeting different epitopes

  • Validate in multiple experimental contexts (ICC, WB, IP)

• Functional validation:

  • Confirm that antibody-detected signals change as expected with experimental manipulation

  • Demonstrate appropriate subcellular localization consistent with protein function

  • Verify changes in expression or localization under conditions known to affect the protein

What technical considerations are important when designing CRISPR/Cas9 targeting strategies for TMEM53-A modification?

For successful CRISPR/Cas9-mediated modification of TMEM53-A in Xenopus laevis, researchers should consider:

• Target site selection:

  • Design guide RNAs targeting early exons shared across all transcripts to ensure complete knockout

  • Target conserved functional domains when creating specific mutations

  • Avoid regions with high GC content or secondary structure that might impair Cas9 access

  • Screen multiple guide RNAs to identify those with highest efficiency

• Allotetraploidy considerations:

  • Account for Xenopus laevis allotetraploidy when designing guides

  • Ensure targeting of both homeologs (TMEM53-A.L and TMEM53-A.S) if complete knockout is desired

  • Design primers that distinguish between homeologs for validation

• Delivery methods:

  • Optimize microinjection parameters for delivering Cas9/gRNA into fertilized eggs

  • Consider using Cas9 protein with in vitro transcribed gRNAs for highest efficiency

  • Implement appropriate controls to assess injection success and embryo viability

• Validation strategies:

  • Design PCR primers flanking the target site for initial screening

  • Perform sequencing to confirm mutations and characterize indel patterns

  • Validate at protein level using Western blot or immunostaining

  • Perform functional assays to confirm altered BMP signaling

How can TMEM53-A research in Xenopus laevis contribute to understanding human skeletal disorders?

Research on TMEM53-A in Xenopus laevis offers valuable insights into human skeletal disorders, particularly sclerosing bone dysplasias (SBDs):

• Comparative disease modeling:

  • TMEM53 mutations in humans cause a previously unknown type of SBD with distinctive skeletal features

  • Xenopus models can help elucidate developmental mechanisms underlying these disorders

  • The conservation of TMEM53 across species suggests functional relevance to human pathology

• Developmental timing insights:

  • Xenopus allows precise developmental staging to determine when TMEM53-A dysfunction first impacts development

  • The transparent nature of Xenopus embryos enables real-time visualization of skeletal development

  • Late-onset phenotypes observed in human patients can be studied in the context of metamorphosis

• Signaling pathway analysis:

  • BMP signaling dysregulation contributes to human skeletal disorders

  • Xenopus models can reveal how TMEM53-A modulates this pathway during normal development

  • Pharmacological interventions targeting BMP signaling can be tested in Xenopus

• Therapeutic strategy development:

  • Rescue experiments in Xenopus can identify potentially therapeutic interventions

  • Drug screening platforms using Xenopus embryos can identify compounds that normalize BMP signaling

  • Gene therapy approaches can be preliminarily tested in this model system

What approaches can be used to investigate potential redundancy between TMEM53-A and other nuclear envelope proteins?

Investigating functional redundancy requires systematic analysis of related proteins:

• Comparative expression analysis:

  • Perform RNA-seq to identify co-expressed nuclear envelope proteins across developmental stages

  • Use single-cell transcriptomics to map expression at cellular resolution

  • Compare protein localization patterns through immunostaining of multiple nuclear envelope proteins

• Combined depletion strategies:

  • Generate single versus double/triple knockouts to identify synthetic phenotypes

  • Perform combinatorial knockdown using morpholinos or RNAi

  • Use graded depletion approaches to identify threshold effects

• Domain-based comparative analysis:

  • Identify proteins with similar functional domains to TMEM53-A

  • Test if these related proteins can rescue TMEM53-A depletion phenotypes

  • Perform domain-swapping experiments to identify functionally equivalent regions

• Evolutionary analysis:

  • Compare nuclear envelope proteomes across species to identify TMEM53-A paralogs

  • Analyze selective pressure on different nuclear envelope proteins

  • Reconstruct evolutionary history of gene duplications and losses

How might TMEM53-A function change during Xenopus metamorphosis?

Xenopus metamorphosis represents a unique developmental transition with profound tissue remodeling, offering an excellent context to study TMEM53-A function:

• Expression analysis during metamorphosis:

  • Perform stage-specific qRT-PCR and Western blotting to track TMEM53-A expression levels

  • Use in situ hybridization to map spatial expression patterns in metamorphosing tissues

  • Compare expression with other nuclear envelope proteins during this transition

• Thyroid hormone responsiveness:

  • Analyze TMEM53-A promoter for thyroid hormone response elements

  • Test if TMEM53-A expression changes in response to exogenous T3/T4

  • Compare expression in control versus thyroid hormone receptor-mutant animals

• Functional studies across metamorphosis:

  • Generate temperature-sensitive or inducible TMEM53-A mutants to control timing of dysfunction

  • Compare pre-metamorphic versus post-metamorphic phenotypes in TMEM53-A mutants

  • Analyze BMP signaling dynamics before, during, and after metamorphosis in normal versus mutant animals

• Tissue-specific functions:

  • Perform tissue-specific knockdown using targeted CRISPR approaches

  • Analyze differential effects on resorbing versus remodeling versus newly forming tissues

  • Compare effects on different ossification modes (intramembranous versus endochondral)